Aikido Pharma has developed a treatment for pancreatic cancer at the University of Texas at Austin - DHA-dFdC. Pancreatic cancer is the 3rd leading cause of cancer-related death in the United States surpassing breast cancer. Get in touch with us today for more information by calling Aikido Pharma at 212-745-1373.
Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.